Recent Company News

• 10:30 PM ET Apr 24, 2025
  

  StreetAccount Sector Preview - Japan Chemicals Jan-Mar Earnings

• 10:36 PM ET Apr 08, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (29 total)

• 08:19 PM ET Apr 08, 2025
  

  EU considering banning use of carbon fibre in automobiles - Nikkei (pre-Japan open)

• 04:07 AM ET Mar 31, 2025
  

  Teijin to transfer all stake in Teijin Automotive Technologies to AURELIUS; terms undisclosed (¥1310.5000, 0)

• 12:40 AM ET Feb 25, 2025
  

  Teijin subsidiary J-TEC enters agreement with Metcela for manufacturing JRM-001 for treatment of single ventricle disease (¥1298.0000, -6)

• 09:39 PM ET Feb 05, 2025
  

  Teijin reports Q3 net income attributable ¥104.3B vs year-ago ¥12.7B (¥1282.0000, +11.5)

• 02:30 AM ET Jan 27, 2025
  

  Street Takeaways - Japan Chemicals Oct-Dec Reporting Season Preview

• 06:05 AM ET Dec 19, 2024
  

  Teijin to sell its 50% stake in JV Esteve Teijin Healthcare to Oximesa for €62M (¥9.92B) (¥1277.0000, 0)

• 09:23 PM ET Dec 12, 2024
  

  Teijin applies for marketing approval in Japan for palopegteriparatide for hypoparathyroidism (¥1306.5000, -12.5)

• 10:14 AM ET Dec 09, 2024
  

  Radius Pharmaceuticals expands abaloparatide (Eladynos) licensing agreement with Theramex granting additional commercialization rights including Mexico, Canada, South Africa, Israel, and Russia ($19.57, +0.78)